Six sites across the U.S. are now engaged in Phase1b study Marlborough, Massachusetts--(Newsfile Corp. -) - Phio ...

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

Valley fever cases are up almost 50% in Arizona in 2024. It's not contagious as a person has to be exposed to fungal spores ...

The National Institutes of Health has awarded the Oklahoma Medical Research Foundation a $412,610 grant for research aimed at ...

November 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future by using its INTASYL ® siRNA gene silencing ...

The partnership will focus on supporting the clinical development of Parabilis’ lead program, FOG-001, in colorectal cancer.

AdventHealth claims top spot; Cleveland Clinic elevated to Masters Category joining Mayo Clinic and Intermountain Healthcare.

A tool powered by artificial intelligence that uses high-speed video to detect changes in blood flow in skin on the face and hands may offer a new way to screen ...

Ariel Investments, an investment management company, released its “Ariel Focus Fund” third-quarter 2024 investor letter. A ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third quarter 2024 investor letter.

The utility of plasma amyloid beta (Aβ) and tau levels for the clinical diagnosis of Alzheimer’s disease ... To achieve this, we recruited a cohort of NC and AD subjects from the Banner Sun Health ...